Home » Topics » BioWorld Science

BioWorld Science
RSS

SHR-1314 studied in phase II/III trial for active ankylosing spondylitis

July 5, 2021

Phase Ib data presented for ulixertinib plus palbociclib in advanced solid tumors

July 5, 2021

GNT-0003 restores UGT1A1 expression in patients with Crigler-Najjar syndrome

July 5, 2021

Sperogenix to develop Abbisko's ABSK-021 for rare neurological diseases in China

July 5, 2021

Patient enrollment begins in phase II study of ADR-001 in severe pneumonia due to COVID-19

July 5, 2021

Pluripotent stem cell-derived CECs for the treatment of corneal dystrophies

July 5, 2021

Amgen starts phase I study of AMG-609 in NAFLD

July 5, 2021

Initiation of phase II trial of Hepalatide in chronic hepatitis B

July 5, 2021

Beijing Tuojie Biopharmaceutical patents CaSR agonists

July 5, 2021

Intestinal MYC modulates weight-related metabolic dysfunction

July 5, 2021

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...